Cancers 2011, 3(2), 2050-2079; doi:10.3390/cancers3022050

Wnt/β-catenin Signaling in Normal and Cancer Stem Cells

, , ,  and * email
Received: 3 March 2011; in revised form: 12 April 2011 / Accepted: 13 April 2011 / Published: 19 April 2011
(This article belongs to the Special Issue Cancer Stem Cells)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: The ability of Wnt ligands to initiate a signaling cascade that results in cytoplasmic stabilization of, and nuclear localization of, β-catenin underlies their ability to regulate progenitor cell differentiation. In this review, we will summarize the current knowledge of the mechanisms underlying Wnt/β-catenin signaling and how the pathway regulates normal differentiation of stem cells in the intestine, mammary gland, and prostate. We will also discuss how dysregulation of the pathway is associated with putative cancer stem cells and the potential therapeutic implications of regulating Wnt signaling.
Keywords: Wnt; β-catenin; stem cells; cancer stem cells; colon; mammary; prostate; therapeutics
PDF Full-text Download PDF Full-Text [719 KB, uploaded 19 April 2011 17:16 CEST]

Export to BibTeX |

MDPI and ACS Style

Valkenburg, K.C.; Graveel, C.R.; Zylstra-Diegel, C.R.; Zhong, Z.; Williams, B.O. Wnt/β-catenin Signaling in Normal and Cancer Stem Cells. Cancers 2011, 3, 2050-2079.

AMA Style

Valkenburg KC, Graveel CR, Zylstra-Diegel CR, Zhong Z, Williams BO. Wnt/β-catenin Signaling in Normal and Cancer Stem Cells. Cancers. 2011; 3(2):2050-2079.

Chicago/Turabian Style

Valkenburg, Kenneth C.; Graveel, Carrie R.; Zylstra-Diegel, Cassandra R.; Zhong, Zhendong; Williams, Bart O. 2011. "Wnt/β-catenin Signaling in Normal and Cancer Stem Cells." Cancers 3, no. 2: 2050-2079.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert